ARTICLE | Financial News
Nivalis Therapeutics proposes IPO
May 18, 2015 7:00 AM UTC
Nivalis Therapeutics Inc., Boulder, Colo. Business: Pulmonary, Inflammation, Autoimmune Date announced: 2015-05-13 Type: IPO To be raised: Up to $60 million Shares: TBD Price: TBD Underwriters: Cowen;...